FDAnews
www.fdanews.com/articles/95358-eli-lilly-divests-distaclor-antibiotic

Eli Lilly Divests Distaclor Antibiotic

July 2, 2007

Eli Lilly and Company, the Indian subsidiary of global pharmaceutical major Eli Lilly, has divested one of its premier antibiotic brands in India — Distaclor (Cefaclor) — to Pharmalink, a subsidiary of Quintiles International, for an undisclosed sum.
Business Standard